<code id='EEBF6D227F'></code><style id='EEBF6D227F'></style>
    • <acronym id='EEBF6D227F'></acronym>
      <center id='EEBF6D227F'><center id='EEBF6D227F'><tfoot id='EEBF6D227F'></tfoot></center><abbr id='EEBF6D227F'><dir id='EEBF6D227F'><tfoot id='EEBF6D227F'></tfoot><noframes id='EEBF6D227F'>

    • <optgroup id='EEBF6D227F'><strike id='EEBF6D227F'><sup id='EEBF6D227F'></sup></strike><code id='EEBF6D227F'></code></optgroup>
        1. <b id='EEBF6D227F'><label id='EEBF6D227F'><select id='EEBF6D227F'><dt id='EEBF6D227F'><span id='EEBF6D227F'></span></dt></select></label></b><u id='EEBF6D227F'></u>
          <i id='EEBF6D227F'><strike id='EEBF6D227F'><tt id='EEBF6D227F'><pre id='EEBF6D227F'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:entertainment    Page View:84752
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In